3D printing; oral solid dosage forms; controlled release; isoniazid; rifampicin; tuberculosis

Ghanizadeh Tabriz, Atabak, Nandi, Uttom, Hurt, Andrew, Hui, Ho-Wah, Karki, Shyam, Gong, Yuchuan, Kumar, Sumit and Douroumis, Dionysios ORCID: 0000-0002-3782-0091 (2020) 3D printed bilayer tablet with dual controlled drug release for tuberculosis treatment. International Journal of Pharmaceutics, 593:120147. ISSN 0378-5173 (doi:https://doi.org/10.1016/j.ijpharm.2020.120147)

solid lipid nanoparticles; curcumin; transferrin; prostate cancer; bioconjugation

Akanda, Md Mushfiq, Getti, Giulia ORCID: 0000-0003-1402-8496 , Nandi, Uttom, Mithu, Md Sadeque Hossain and Douroumis, Dionysios ORCID: 0000-0002-3782-0091 (2021) Bioconjugated solid lipid nanoparticles (SLNs) for targeted prostate cancer therapy. International Journal of Pharmaceutics, 599:120416. ISSN 0378-5173 (doi:https://doi.org/10.1016/j.ijpharm.2021.120416)